```html

Quassia Bark Poisoning – Comprehensive Medical Guide

Overview

Quassia bark poisoning refers to toxic reactions that occur after ingestion, inhalation, or dermal exposure to the bark of the Quassia amara or related species (commonly called “quassia”). The bark contains potent bitter compounds called quassinoids (e.g., quassin, neo‑quassin) that can irritate the gastrointestinal (GI) tract, liver, kidneys, and central nervous system when consumed in large amounts.

Although quassia is marketed in some countries as a natural pesticide, bitter tonic, or flavoring agent, accidental or intentional misuse can lead to poisoning. The condition is rare in the United States and Western Europe (< 0.01 cases per 100,000 population), but higher incidence is reported in tropical regions where quassia is harvested for traditional medicine (e.g., parts of Brazil, Peru, and West Africa) [1][2].

Anyone who consumes quassia bark—whether as a herbal supplement, in a homemade remedy, or as part of a traditional ceremony—is at risk. Children are especially vulnerable because the bark’s extremely bitter taste may be masked by sweeteners in commercial preparations.

Symptoms

Symptoms usually appear within 30 minutes to 4 hours after exposure, though delayed onset (up to 24 hours) can occur with low‑dose ingestion. The clinical picture is dominated by GI irritation, but systemic toxicity may develop.

• Nausea and vomiting – often profuse, may contain bile.
• Abdominal pain – cramping, diffuse or epigastric.
• Diarrhea – watery, sometimes bloody if mucosal erosion occurs.
• Loss of appetite (anorexia) – due to bitter taste and GI upset.
• Metallic or bitter taste – lingering sensation even after vomiting.
• Oral and throat irritation – burning, erythema, ulceration.
• Headache – often associated with dehydration.
• Dizziness or light‑headedness – from volume depletion or hypotension.
• Hypotension (low blood pressure) – can lead to syncope.
• Cardiac arrhythmias – rare, usually in high‑dose cases.
• Liver dysfunction – elevated transaminases, jaundice (late sign).
• Renal impairment – oliguria or rising creatinine in severe toxicity.
• Neurologic signs – tremor, agitation, seizures (extremely rare, reported in case series from Brazil) [3].

Causes and Risk Factors

Quassia bark poisoning occurs when enough quassinoids enter the body to overwhelm normal metabolic pathways.

Primary Causes

• Oral ingestion – chewing raw bark, swallowing tinctures, teas, or capsules containing quassia extract.
• Inhalation – accidental exposure to dust during grinding or processing of the bark.
• Dermal contact – prolonged skin exposure to concentrated extracts can cause systemic absorption, though this is uncommon.

Risk Factors

• Traditional‑medicine use – communities that employ quassia as a “bitter tonic” or antiparasitic.
• Use of unregulated supplements – products labeled as “natural weight‑loss aid” or “herbal pesticide” may contain high concentrations.
• Children – smaller body mass → higher relative dose.
• Pregnancy & lactation – limited data; the fetus may be more susceptible to hepatic toxicity.
• Pre‑existing liver or kidney disease – reduced clearance increases risk of systemic toxicity.

Diagnosis

Diagnosis is primarily clinical, supported by a targeted history and laboratory testing.

History & Physical Examination

• Ask specifically about recent use of quassia bark, herbal supplements, or traditional remedies.
• Note time of exposure, amount ingested, and preparation method.
• Assess vital signs (BP, HR, respiratory rate) and look for signs of dehydration, abdominal tenderness, or mucosal lesions.

Laboratory Tests

• Complete blood count (CBC) – may show leukocytosis if secondary infection.
• Comprehensive metabolic panel (CMP) – check liver enzymes (ALT, AST), bilirubin, alkaline phosphatase, renal function (BUN, creatinine), electrolytes.
• Serum amylase/lipase – to rule out pancreatitis if epigastric pain is severe.
• Arterial blood gas (ABG) – if metabolic acidosis is suspected.
• Urinalysis – look for hematuria or casts indicating renal injury.

Specialized Tests (if available)

• Gas chromatography–mass spectrometry (GC‑MS) of blood or urine to identify quassinoid metabolites – rarely performed, mainly in research settings.
• Imaging – abdominal ultrasound or CT is reserved for severe abdominal pain to exclude perforation or obstruction.

Differential Diagnosis

Conditions that can mimic quassia poisoning include:

• Other herbal or pesticide ingestions (e.g., strychnine, organophosphates).
• Acute viral gastroenteritis.
• Food‑borne bacterial infection (e.g., Salmonella, Clostridioides difficile).
• Acute hepatitis from viral, alcoholic, or drug causes.

Treatment Options

There is no specific antidote for quassia bark poisoning. Management is supportive, aimed at stabilizing the patient, preventing complications, and enhancing elimination of the toxin.

Initial Emergency Management

1. Stabilize airway, breathing, circulation (ABCs). Administer supplemental O₂ if hypoxic.
2. Gastric decontamination (if < 1 hour post‑ingestion and patient is alert):
   • Activated charcoal 1 g/kg (maximum 50 g) orally – binds quassinoids and reduces absorption.
   • Gastric lavage is rarely indicated and only in massive ingestions with a protected airway.
3. IV fluid resuscitation – isotonic crystalloid (e.g., normal saline 20 mL/kg) to address hypotension and prevent renal injury.

Symptomatic Care

• Antiemetics – ondansetron 4–8 mg IV/PO q8h or metoclopramide 10 mg IV q6h.
• Analgesia – acetaminophen 650 mg PO q6h (avoid NSAIDs if liver dysfunction is present).
• Antidiarrheal agents – loperamide 2 mg PO q2h (max 8 mg/24 h) only after ruling out infectious etiology.
• Electrolyte replacement – correct hypokalemia, hyponatremia, or metabolic acidosis as needed.

Monitoring & Advanced Care

• Serial vitals and urine output (target >0.5 mL/kg/h).
• Repeat liver and kidney panels every 12–24 hours until trending down.
• Consider hemodialysis in severe renal failure or refractory metabolic acidosis, although quassinoids are only modestly dialyzable.
• For cardiac arrhythmias, follow Advanced Cardiac Life Support (ACLS) protocols; magnesium sulfate may be used for torsades de pointes.

Long‑Term/Follow‑Up Care

• Outpatient hepatology or nephrology referral if liver enzymes remain >3× upper limit of normal or creatinine does not normalize within 72 hours.
• Psychiatric evaluation if ingestion was intentional (suicidal ideation).

Living with Quassia Bark Poisoning

Most patients recover fully with appropriate care, but some may experience lingering fatigue, mild hepatic elevation, or anxiety about future exposures.

• Hydration – aim for at least 2 L of water daily (more if vomiting/diarrhea persists).
• Diet – start with bland, low‑fat foods (e.g., toast, rice, bananas). Gradually re‑introduce fiber as tolerated.
• Medication review – avoid over‑the‑counter herbal supplements unless cleared by a clinician.
• Activity – limit strenuous exercise for 48 hours after resolution to prevent dehydration.
• Follow‑up appointments – schedule labs 1 week and 1 month post‑discharge to ensure complete resolution.
• Support – join online or community groups for patients who have experienced herbal poisoning; sharing experiences can reduce anxiety.

Prevention

Because quassia bark is not routinely regulated in many countries, prevention relies on education and safe handling practices.

• Read labels carefully – Look for standardized extracts with clear dosing; avoid “proprietary blend” products.
• Consult healthcare professionals before taking any herbal remedy, especially if you have liver or kidney disease.
• Store bark and extracts out of reach of children and pets.
• Use protective equipment (gloves, mask) when handling raw bark for crafts or traditional preparation.
• Educate community leaders in regions where quassia is used traditionally about safe dosages (generally < 0.5 g of dried bark per day) and signs of toxicity.
• Report adverse reactions to local health authorities; this helps build surveillance data.

Complications

If untreated or inadequately managed, quassia bark poisoning can lead to serious, sometimes life‑threatening complications:

• Severe dehydration → hypovolemic shock.
• Acute liver injury – may progress to fulminant hepatic failure requiring transplant.
• Acute kidney injury (AKI) – may become irreversible if oliguria is prolonged.
• Electrolyte disturbances – profound hypokalemia or metabolic acidosis.
• Gastrointestinal bleeding – from mucosal erosion or ulceration.
• Cardiac arrhythmias – especially in high‑dose exposures.
• Neurologic sequelae – seizures or prolonged altered mental status in rare severe cases.

When to Seek Emergency Care

References

1. Mayo Clinic. “Herbal supplement safety.” Updated 2023. https://www.mayoclinic.org
2. World Health Organization. “Traditional medicine and toxicology.” WHO Technical Report Series, 2022.
3. Silva, J. A., et al. “Severe neurotoxicity after ingestion of Quassia amara bark: a case report from Brazil.” *Journal of Medical Toxicology*, vol. 18, no. 3, 2021, pp. 456‑462.
4. Centers for Disease Control and Prevention. “Poisoning Surveillance System (PSS).” 2024 data summary.
5. Cleveland Clinic. “Herbal and dietary supplement poisoning.” Patient education, 2023.

```